FDA gives listings of medical research in regenerative medication

Food and Drug Administration officials hope they can help connect veterinarians and pet owners with clinical trials of regenerative medicine in animals.

In February, agency officials began populating a website with information on clinical trials involving the use of animal cells, tissues, and cell- and tissue-based products in veterinary patients. Registered animals can be pets or farm animals. At the time of going to press, the website had listings for studies of stem cell-related treatments for chronic gingivostomatitis in cats, chronic enteropathy in cats, and spina bifida in English bulldogs.

“We offer this website as a resource because we’ve heard from veterinarians and pet owners who are eager to participate in clinical trials and offer their patients and pets the potential of regenerative veterinary medicine,” the agency said in an announcement. “Linking interested pet owners and their veterinary teams to relevant clinical trials also helps sponsors generate data for potential FDA approval.”

The website provides information on the types and conditions of each research study, the products used, and the recruitment and study periods, and contact information for each product sponsor.